1. Home
  2. KTTA vs CNF Comparison

KTTA vs CNF Comparison

Compare KTTA & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.48

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

CNF

CNFinance Holdings Limited each representing twenty (20)

HOLD

Current Price

$1.99

Market Cap

34.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
CNF
Founded
2020
1999
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
34.6M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
KTTA
CNF
Price
$0.48
$1.99
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $3.00
N/A
AVG Volume (30 Days)
★ 191.9K
4.7K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.07
N/A
EPS
N/A
★ N/A
Revenue
★ $486,559.00
N/A
Revenue This Year
N/A
$252.34
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.28
$1.74
52 Week High
$2.06
$6.49

Technical Indicators

Market Signals
Indicator
KTTA
CNF
Relative Strength Index (RSI) 37.17 48.05
Support Level $0.43 N/A
Resistance Level $0.52 $2.40
Average True Range (ATR) 0.03 0.10
MACD -0.01 0.02
Stochastic Oscillator 13.72 62.50

Price Performance

Historical Comparison
KTTA
CNF

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.

Share on Social Networks: